Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Aortic Aneurysm, Thoracic
- Aortic Valve Stenosis
- Coronary (Artery) Disease
- Mitral Valve Disease
- Postoperative Complications
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Randomized controlled 1:1Masking: Triple (Participant, Investigator, Outcomes Assessor)Masking Description: Double blinding, study drug administration by separate staff blinded from participant and investigatorsPrimary Purpose: Prevention
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03574311
- Collaborators
- Vifor Pharma
- Investigators
- Not Provided
Get Well Soon